You are here

LUPUS NEFRİTİNİN PATOGENEZİNDE YENİ GELİŞMELER

NEW INSIGHTS IN THE PATHOGENESIS OF LUPUS NEPHRITIS

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Systemic Lupus Erythematosus (SLE) is a prevalent disease that shows all the characteristics of an autoimmune pathology. The developments in the pathogenic factors in SLE provide new insights to the treatment of SLE and also provide new informations about many other diseases. In this review in the light of our cases, new developments about SLE and lupus nephritis wil be discussed.
Abstract (Original Language): 
Sistemik Lupus Eritematosus (SLE) toplumda yaygın olarak görülen ve otoimmun hastalıkların hemen bütün özelliklerini üzerinde taşıyan ilginç bir hastalıktır.Son yıllarda SLE patogenezinde yaşanan önemli gelişmeler SLE tedavisine katkılarının yanı ura diğer hastalıkların oluş mekanizmaları ve tedavilerine de ışık tutacaktır. Bu derlemede bu gelişmelerden kısaca bahsedilecek ve konu ile ilgili kendi hasta grubumuzun verileri tartışılacaktır.
FULL TEXT (PDF): 

REFERENCES

References: 

1.
Boumpa
s DT, Austin III HA, Fessler BJ, et al. Systemic
lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995; 122: 940¬950
2. Karakoç Y, Dilek K, Güllülü M, Yavuz M, Ersoy A,
Akalın
H
, Yurtkuran M. Prevalence of hepatitis C virus antibody in patients with SLE. Ann Rheum Dis 1997; 56: 570-571
3. Churg J, Bernstein J, Glassock RJ. Lupus nephritis, in Renal Disease, Classification and Atlas of Glomerular Diseases, edited by Churg J, Bernstein J, Glasscock R.I,
New York, Igaku-Shoin, 1995, p 151
4. Ter Borg EJ, Horst G, Hummel Ej, Limburg PC, Kallenberg CGM. Predictive values of rises in anti-double-stranded DNA anti-body levels for disease exacerbations in systemic lupus erythematosus: a long term prospective study. Arthritis Rheum 1990; 33: 634¬643
5. Kalunian KC, Panosian-Shakian N, Ebling FM, et at. Idiotypic characteristics of immunoglobulins associated with systemic lupus erythematosus. Arthritis Rheum
1989;32:513-522
6. Koffler D, Agnello V, Thoburn R, Kunkel HG. SLE,
prototype of immune complex nephritis in man. J Exp Med 1971; 134: 169- 179
7. Eilat D. Crossreactions of anti-DNA antibodies and the central dogma of lupus nephritis. Immunol Today 1988; 6: 123-127
8. Dziarski R. Autoimmunity: Policlonal activation or antigen induction. Immunol Today 1988; 9: 340-342
9. Lafer EM, Rauch J, Andrzejewski C Jr, et al. Polyspecific monoclonal lupus autoantibodies reactive with polynucleotides and phospholipids. J Exp Med 1981; 153:897-909
10. Faaber P, Rıjke GPM, Van De Putte LBA, et al.
Crossreactivity of human and murine anti-DNA antibodies with heparan sulphate: the major glycosaminogliycan in glomerular basement membrane.
J Clin Invest 1986; 77: 1824-1830
11. Foster MH, Cizman B, Madaio MP. Biology of disease. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanism of immune deposition, and genetic origin.
Lab Invest 1993; 69: 494-507
111
12. Jacob L, Viard JD, Allenet N, et al. A monoclonal anti-duble-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex. Proc Natl Acad Sci USA 1989; 86: 4669-4673
13. Termaat RM, Brinkman K, Van Gompel F, et al. Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulphate is mediated via bound DNA/histone complex. J Autoimmun 1990; 3: 531-545
14. Termaat RM, Assmann KJM, Van Son JPHF, et al.
Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes. Lab Invest 1993; 68: 164-173
15. Chan TM, Frampton G, Staines NA, et al. Different mechanism by which anti-DNA Moabs bind to human endothelial cells and glomerular mesangial cells. Clin
Exp Immunol 1992; 88: 68-74
16. Brinkman K, Termaat RM, Berden JHM, Smeenk RJT.
Anti-DNA antibodies and lupus nephritis: the complexity of crossreactivity. Immunol today 1990; 11:
232-234
17. Kramers C, Hylkema NM, Van Bruggen MCI, et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest
1994;94:568-577
18. Diamond B, Katz JB, Paul E, et al. The role of somatic mutation in the pathogenic anti-DNA response. Ann.
Rev Immunol 1992; 10: 731-757
19. Bell DA, Morrison B, Vandenbygarrt P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymhoid cells stimulate proliferation and immunglobulin synthesis of normal
mouse lymhocytes. J Clin Invest 1990; 85: 1487-1496
20. Burlingame RW, Boey ML, Starkebaum G, Rubin RL.
The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus. J Clin Invest 1994; 94: 184-192
21. Chabre H, Amoura Z, Piette JC, et al. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arhritis Rheum 1995;
38: 1485-1491
22. Bernstein KA, Di Valerio R, Lefkowith JB. Glomerular binding activity in MRL Ipr serum consist of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 1995; 154: 2424-2433
23. Rumore PM, Steinmann CR. Endegenous circulating DNA in systemic lupus erythematosus. Occurence as multimeric complexes bound to histone. J Clin Invest
1990; 86: 69-74
24. Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152: 3685-3692
25. Watanabe-Fukunaga R, Brannan CI, Copeland NG, et al. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature
1992:356:314-317
26. Singer GG, Carrera AC, Marshak-Rothstein A, et al. Apoptosis, Fas and systemic autoimmunity: the
MRL/lpr model. Curr Opin Immunol 1994; 6: 913-920
27. Nagata S, Suda T. Fas and Fas ligand: Ipr and gld mutations. Immunol Today 1995; 16: 39-43
28. Strasser A, Whittingham S, Vaux DL, et al. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and exhibits autoimmune diseases. Proc Natl Acad Sci USA 1991; 88: 8661-8665
29. Siegert CEH, Daha MR, Westedt ML, Van Der Voort
EAM, Breedveld FC. IgG autoantibodies against Clq are correlated with nephritis, hypocomplementaemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 1991; 18: 230-234
30. Siegert CEH, Daha MR, Tseng C, et al. Predictive value of IgG autoantibodies against Clq for nephritis in systemic lupus erythematosus. Ann Rheum Dis
1993;52:851-856
112

Thank you for copying data from http://www.arastirmax.com